©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 505-515
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.505
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.505
Table 1 Baseline clinical characteristics of the enrolled patients
| Characteristics | Patients (n = 1868) |
| Mean age (range), yr | 65 (28-93) |
| Gender | |
| Male | 1072 (57.4) |
| Female | 796 (42.6) |
| Location | |
| Colon | 892 (47.8) |
| Rectum | 957 (51.2) |
| Unknown | 19 (1.0) |
| Histology | |
| Well differentiated | 484 (25.9) |
| Moderate differentiated | 1066 (57.1) |
| Poorly differentiated | 139 (7.4) |
| Unknown | 179 (9.6) |
| Tumor stage | |
| I | 281 (15.0) |
| II | 551 (29.5) |
| III | 667 (35.7) |
| IV | 369 (19.8) |
| Chemotherapy | |
| No | 294 (15.8) |
| Yes | 1574 (84.2) |
- Citation: Kim JH, Lee JY, Kim HK, Lee JW, Jung SG, Jung K, Kim SE, Moon W, Park MI, Park SJ. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 2017; 23(3): 505-515
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/505.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.505